Accelerating Biopharmaceutical Development
The Pfēnex Expression Technology™ platform uniquely positions Pfēnex Inc. to address production of proteins to serve a wide range of markets and fulfill an unmet need for rapid reliable protein production development. The Pfēnex product pipeline currently contains biosimilar proteins advantaged over innovator proteins through improvements in expression titer and product quality, biodefense molecules that meet increasingly stringent standards for speed of delivery and product quality, and novel vaccine antigens to address existing and emerging diseases.